ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3254

Use of the Short Valued Life Activities Scale in People with Systemic Sclerosis

Janet L. Poole1 and Betty Skipper2,3, 1Health Sciences Ctr OT Program, 1 University of New Mexico, Albuquerque, NM, 2Family and Community Medicine, University of New Mexico, Albuquerque, NM, 3Family and Community Medicine, University of New Mexico, University of New Mexico, Albuquerque, NM

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: activities of daily living (ADL) and systemic sclerosis, Participation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 16, 2016

Title: ARHP VI: Rehabilitation Sciences

Session Type: ARHP Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose:   Systemic sclerosis is a chronic autoimmune connective tissue disorder that results in skin thickening, vascular insufficiency, and fibrosis of internal organs, such as the heart, lungs, kidneys, gastrointestinal tract, and joints and muscles. People have difficulty participating in daily tasks due to pain, finger ulcers, Raynaud’s phenomenon, and internal organ involvement, particularly decreased pulmonary function. Most of the research on scleroderma has focused on performance of basic daily living and work tasks. Little is known about participation in household, leisure, and community activities. The Valued Life Activities Scale (VLA) measures difficulty in self-care, household, leisure and community activities (1). The VLA has been used to track changes over time in persons with different rheumatic diseases and thus, maybe useful for people with scleroderma. However, the 33 items may be too long for clinical use. Purpose: To examine the internal consistency and validity of the 14 item Short-VLA Scale in persons with systemic sclerosis.

Methods:   The sample was a convenience sample of 83 people with systemic sclerosis recruited from the Scleroderma Foundation website and annual conference. Participants completed the VLA, a questionnaire with 33 items under three domains: obligatory, committed, and discretionary. Obligatory activities include self-care, committed activities include household tasks, and discretionary activities include leisure and community activities. For each item, participants rated difficulty with performance from 0 (no difficulty) to 3 (unable to do). A Short-VLA score is calculated as the mean from 14 of the items as described by Katz et al.(2). Participants also completed a demographics questionnaire, questions regarding the presence and severity of disease symptoms, the Health Assessment Questionnaire (HAQ), and Center for Epidemiologic Studies Depression Scale (CES-D) and the Adelaide Activities Profile (AAP), a measure of frequency of participation in household and community tasks.

Results:   The majority of the participants were Caucasian (94%), female (90%), and married; 98% had Raynaud’s phenomenon, 93% reported gastrointestinal problems and 50% reported lung involvement. Our participants had a mean age of 53 years and mean disease duration of 9 years. About half of the participants had limited SSc and half had diffuse SSc. The mean score on the S-VLA was 1.10 indicating mild difficulty. Internal consistency of the S-VLA was excellent (Cronbach’s alpha=0.92). The correlation between the S-VLA and the original long form VLA was excellent (r=0.96). A moderate correlation was also found between the S-VLA and the HAQ (r=0.73) and AAP (r = 0.56), however the correlation with the CES-D was only fair (r=0.35).

Conclusion:   The S-VLA was found to be a reliable and valid measure in persons with SSc. In addition, the S-VLA may be useful to monitor participation in household, leisure, and community activities as decreasing participation in these types of activities has been correlated with depression and decreased quality of life (1).

  1. Katz PP et al. Ann Rheum Dis 2006; 65; 763-9.
  2. Katz PP et al. Arthritis Care Res 2011; 63; 1664-71.

Disclosure: J. L. Poole, PCORI grant, 2; B. Skipper, None.

To cite this abstract in AMA style:

Poole JL, Skipper B. Use of the Short Valued Life Activities Scale in People with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/use-of-the-short-valued-life-activities-scale-in-people-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-the-short-valued-life-activities-scale-in-people-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology